期刊文献+

高效抗逆转录病毒治疗对AIDS患者MCP-1和MSP水平的影响 被引量:1

Impact of highly active antiretroviral therapy on plasma MCP-1 and MSP in AIDS patients
下载PDF
导出
摘要 目的:研究高效抗逆转录病毒治疗(HAART)对AIDS患者血清中MCP-1、MSP水平的影响。方法:采用ELISA法检测40例经HAART3个月的国内AIDS患者及84例经HAART3至6年的德国患者血清MCP-1、MSP的水平,荧光定量PCR测定HIV-RNA滴度,流式细胞术检测CD4+T细胞计数。结果:HIV-1感染者血清MCP-1的水平显著高于正常人群(P<0.01),MSP则显著低于正常人群(P<0.01);经短期HAART(3月)后,MCP-1水平下降(P<0.01),MSP无明显改变;长期HAART(3至6年)后MCP-1水平显著升高(P<0.01),而MSP显著下降(P<0.01),MCP-1和MSP水平的变化呈负相关(r=-0.99,P=0.029)。结论:MCP-1、MSP与AIDS病程进展有密切关系,HAART对AIDS患者MCP-1、MSP水平有显著的改变,进而改善患者病程进展。 Objective: To study the effect of highly active antiretroviral therapy (HAART) on plasma levels of MSP and MCP-1 in AIDS patients. Methods: Forty Chinese AIDS patients were treated with HAART for 3 months and 84 German AIDS patients with HAART for 3 to 6 years.The pre-treatment and post-treatment plasma levels of MSP and MCP-1 were measured by enzyme-linked immunosorbent assay (ELISA),and their correlations with CD4+ cell counts and viral loads were analyzed. Results: The mean levels of MCP-1 were significantly higher and MSP were significantly lower in HIV-infected patients compared with the HIV-negative controls (P〈 0. 01). After HAART for three months,there were no significant changes in the levels of these cytokines. But after long-term HAART (for 3 to 6 y),the level of MCP-1 was increased and that of MSP decreased significantly (P〈0. 01). There was a negative correlation between MSP and MCP-1 levels,and the same for MSP level and CD4+cell counts; while there was a positive correlation between MCP-1 levels and CD4+ cell counts. Conclusion: The changed plasma levels of MSP and MCP-1 are associated with HIV-1 infection and HAART may reverse the levels of these two cytokines.
出处 《浙江大学学报(医学版)》 CAS CSCD 2007年第2期174-178,共5页 Journal of Zhejiang University(Medical Sciences)
基金 国家"十五"攻关项目 项目编号:2004BA719A10
关键词 获得性免疫缺陷综合征/药物疗法 抗逆转录病毒治疗 高效/方法 人类免疫缺陷病毒 巨噬细胞刺激蛋白 巨噬细胞趋化蛋白 Acquired immunodeficiency syndrome/drug ther Antiretroviral therapy,highly active/methods HIV-1 infecion MCP-1 MSP
  • 相关文献

参考文献18

  • 1PRUSINER S B. Historical essay: Discovering the cause oI AIDS [J]. Science,2002,298(5599) :1 726.
  • 2STEVENSON M. HIV-1 pathogenesis [J]. Nat Med, 2003,9 (7) : 853-860.
  • 3李丹,吴南屏,Armin Bader,Hoxtermann Stefan,Norbert Brockmeyer.高效抗逆转录病毒治疗对T细胞亚群上第二受体影响的研究[J].浙江大学学报(医学版),2003,32(2):97-100. 被引量:4
  • 4KUMAE S N,BOSS J M. Site A of the MCP-1 distal regulatory region functions as a transcriptional modulator through the transcription factor NF1 [J]. Mol Immunol,2000,37 (11), 623- 632.
  • 5ROLLINS B J, WALZ A. Recombinant human MCP-1/JE induces chemotaxis,calciumflux,and the respiratory burst in human monocytes [J].Blood,1991,78(4):1 112-1 116.
  • 6JIANG Y L, BELLER D I. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes [J]. J Immunol ,1992,148(8) :2 423-2 428.
  • 7SANDERS V J,PITTMAN C A,WHITE M G,et al. Chemokines and receptors in HIV encephalitis [J]. AIDS, 1998,12 (9) : 1 021-1 026.
  • 8EUGENIN E A,D'AVERSA T G,LOPEZ L,et al. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-inducedapoptosis [J].J Neuroehem, 2003,85 (5) : 1 299-1 311.
  • 9MONTEIRO de ALMEIDA S, LETENDRE S,ZIMMERMAN J,et al. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma [J]. J Neuroimmunol, 2005,169 (1-2):144-152.
  • 10MELLADO M, RODRIGUEZ-FRADE J M,VILA-CORO A J,et al. Chemokine control of HIV-1 infection [J]. Nature, 1999,400 ( 6746 ) :723-724.

二级参考文献5

  • 1[1]Bjorndal A, Deng H, Jansson M, et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype [J]. J Virol, 1997,71(10):7478-7487.
  • 2[2]Mo H, Monard S, Pollack H, et al. Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood [J]. AIDS Res Hum Retroviruses,1998,14(7):607-617.
  • 3[3]Nicholson J K,Browning S W,Hengel R L,et al.CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy [J]. J Acquir Immune Defic Syndr, 2001,27(2):105-115.
  • 4[4]Pierdominici M,Giovannetti A,Ensoli F,et al.Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy [J]. J Acquir Immune Defic Syndr, 2002,29(2):122-131.
  • 5[5]Foussat A, Bouchet D L, Berrebi D, et al. Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients [J]. Blood, 2001,98(6):1678-1686.

共引文献3

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部